Which Parathyroid hormone is indicated for building new bone and is administered daily through injection?

• A. Sclerostin Inhibitor
• B. Romosozumab
• C. Teriparatide
• D. Abaloparatide

Answer: (C)

The correct answer is Teriparatide. This medication is a synthetic form of parathyroid hormone (PTH) and is specifically designed to stimulate bone formation. It works by promoting the activity of osteoblasts, the cells responsible for bone synthesis, thereby increasing new bone growth and improving bone density.

Teriparatide is administered daily via subcutaneous injection and is primarily used in patients with osteoporosis who are at high risk for fractures. It has been shown to significantly enhance bone mineral density and reduce the risk of vertebral and nonvertebral fractures.

Understanding the role of Teriparatide is crucial for recognizing its therapeutic potential in treating osteoporosis and addressing bone health. Other options like Sclerostin Inhibitors, Romosozumab, and Abaloparatide are also associated with bone treatments, but they function through different mechanisms or are not specifically identified as direct forms of PTH designed for daily injection.